Drug developer QLT announces plan to buy back 3.4 million shares over next year

VANCOUVER – Eye drug developer QLT Inc. (TSX:QLT) said Thursday it plans to buy back up to 3.4 million of its shares over the next year as the first step in a plan to return $100 million in shareholders.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.